Francesco De Rubertis

Insider Reports History

Entity
Individual
Location
C/O Medicxi, Cours De Rive 10, Geneva, Switzerland
Signature
/s/ Marella Thorell, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francesco De Rubertis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Director Ordinary Shares 281K $2.24M $7.96 Mar 21, 2022 Indirect

Insider Reports Filed by Francesco De Rubertis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNTA Centessa Pharmaceuticals plc Mar 21, 2022 2 $0 4 Mar 23, 2022 Director
CNTA Centessa Pharmaceuticals plc Dec 2, 2021 2 $440K 4 Dec 6, 2021 Director
CNTA Centessa Pharmaceuticals plc Nov 30, 2021 4 $1.19M 4 Dec 2, 2021 Director
CNTA Centessa Pharmaceuticals plc Nov 26, 2021 4 $797K 4 Nov 30, 2021 Director
CNTA Centessa Pharmaceuticals plc May 27, 2021 0 $0 3 May 27, 2021 Director
CNTA Centessa Pharmaceuticals plc Jan 29, 2021 8 $33.2M 4 Jun 4, 2021 Director